News
- 14 September, 2022
ideSHi has identified two SARS-CoV-2 Omicron sublineage which have been detected in patients from Dhaka city between August to September, 2022. These two include BA.2.75 and BA.2.10.1 (also designated as BJ1). These were first identified in India in May 2022. At present, BA.2.75 is the most dominant subvariant in India while BJ1 has also been […]
- 22 June, 2022
ideSHi Offers Cholera Vaccination for the Hajj Pilgrims. Oral Cholera Vaccine (Cholvax) is available at ideSHi for the Hajj pilgrims as per direction by the Bangladesh Haj Management Portal, Ministry of Religious Affairs.
- 01 June, 2022
Introducing our new Chief Operating Officer (COO) Dr. Sharmin Akhter Zahan, a global health professional, joined ideSHi, as its Chief Operating Officer. Previously, she was Head of Ecosystem and Business Development at Digital Healthcare Solutions and Telenor Health AS of Grameen. Dr. Zahan is trained in Medicine, Public Health, and Global Health with almost 20 […]
- 29 March, 2022
Diagnosis of infectious diseases is the prerequisite for proper treatment. Determining correctly the presence, absence, or evidence of previous existence of pathogens like viruses, bacteria, fungi and other parasites can make the difference between losing and saving a patient. When it comes to areas of diagnostics, microbiology is a major discipline. Every day across the […]
